bioAffinity Technologies Reports Fourth Quarter and Full Yea

31.03.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three and 12 months ended ...

Related Keywords

University Of Texas At San Antonio , Texas , United States , United Kingdom , China , Sweden , Italy , Hong Kong , Australia , Mexico , Spain , France , Germany , Canada , American , Alvaro Souto Padron , David Hill , Maria Zannes , Rossella Titone , Sheila Habib , Julie Anne Overton , Affinity Technologies Inc , Laboratory Developed Test , Oncoselect Therapeutics , Paycheck Protection Program , Drug Administration , Precision Pathology Services , Company Scientific , Nasdaq , Yale University School Of Medicine , Respiratory Research , Affinity Technologie , Cypath Lung , Chronic Obstructive Pulmonary Disease , Visualized Experiments , Modified Beads , Compensation Controls , Medical Advisory Board , Pulmonary Lung Nodule Clinic , Lung Cancer Screening Program , South Texas Veterans Health Care , National Board Member , American Lung Association , Yale University School , Alvaro Souto Padron De Figueiredo , Affinity Technologies , Chief Executive Officer , Path Lung , Investor Relations , Precision Pathology , Protection Program , Years Ended December , Affinity Technologies Stock , Bioaffinity Technologies ,